BMY(Bristol-Myers Squibb Company) 的内部人交易:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-05 | Haller Julia A | 董事 | 公开市场卖出 | 3,800 | $63.31 |
| 2026-09-09 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | 公开市场卖出 | 6,249 | $64.57 |
| 2026-08-25 | Holzer Phil M | SVP and Controller | 公开市场卖出 | 500 | $67.50 |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | 公开市场卖出 | 4,481 | $62.05 |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | 公开市场卖出 | 25,519 | $61.60 |
| 2025-09-02 | Elkins David V | EVP, Chief Financial Officer | 公开市场卖出 | 56,000 | $47.33 |
| 2025-08-02 | Short Bartie Wendy | EVP, Corporate Affairs | 公开市场卖出 | 378 | $44.23 |
| 2025-05-09 | Hickey Benjamin | President, RayzeBio Org. | 公开市场卖出 | 97 | $38.01 |
| 2025-04-25 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 公开市场买入 | 4,250 | $47.58 |
| 2025-02-20 | BOERNER CHRISTOPHER S. | Chief Executive Officer | 公开市场买入 | 2,000 | $55.05 |
| 2025-02-14 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 公开市场买入 | 1,823 | $54.84 |